Zion Market Research has published a new report titled “Bioresorbable Implants Market by Type (Metallic and Polymer), by Application (Orthopedic, Cardiovascular, and Others), and by End-User (Hospital, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2027”. (Sample Copy Here) According to the report, the global bioresorbable implants market was approximately USD 4,958 million in 2018 and is expected to generate around USD 10,041 million by 2027, at a CAGR of around 8.1% between 2019 and 2027.
Bioresorbable implants play a key role in advanced healthcare, as they improve and support damaged biological structure in the body. They are biologically integrated into the body, which decomposes after a specified period of time. It provides temporary support to the body to heal the damaged tissues. Bioresorbable implants are used in numerous orthopedic, dental, and cardiovascular surgeries, which is the primary growth driver of the bioresorbable implants market globally.
Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/bioresorbable-implants-market
Furthermore, the high incidence of cardiovascular disease globally is anticipated to propel the demand for bioresorbable implants for cardiovascular surgeries, which, in turn, is predicted to boost the global bioresorbable implants market development over the forecast time period. Moreover, the increasing incidences of skeletal injuries are also likely to boost the bioresorbable implants market globally in the future. Additionally, the growing competition among the key players operating in the bioresorbable implants market for the development of innovative solutions is further anticipated to propel this market’s growth in the future.
The global bioresorbable implants market is categorized into type, application, and end-user. On the basis of type, the bioresorbable implants market includes metallic and polymer. The polymer segment is further divided into PLLA- Poly L-lactide, PLGA- Polylactic-co-glycolic acid, PLA- Polylactic Acid, PGA- Polyglycolic Acid, and others. The polymer segment accounted for the largest share in 2018, i.e., more than 80%, in the global market. Bioresorbable polymers are also called degradable or bioresorbable polymers, as they can be securely absorbed in the body.
Get Sample Report for More Details @ https://www.zionmarketresearch.com/sample/bioresorbable-implants-market
By application, the global bioresorbable implants market is fragmented into orthopedic, cardiovascular, and others. The orthopedics segment held the largest share in the global bioresorbable implants market in 2018, due to the growing incidences of orthopedic diseases and surgeries.
On the basis of end-user, the global bioresorbable implants market includes hospitals, ambulatory surgical centers, and others. Hospitals accounted for the largest share in the global bioresorbable implants market in 2018 and are expected to remain dominant over the forecast time period as well.
By geography, North America accounted for the largest share of the global market in 2018 and is anticipated to remain the leading region over the forecast time period as well. The Asia Pacific region is expected to register the highest rate of growth in the global bioresorbable implants market in the future.
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/bioresorbable-implants-market
Some major players of the global bioresorbable implants market are Bioretec, CONMED Corporation, DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew, and Boston Scientific Corporation.
This report segments the global bioresorbable implants market into:
Global Bioresorbable Implants Market: Type Analysis
- PLGA-Poly lactic-co-glycolic acid
- PLLA-Poly L-lactide
- PGA-Polyglycolic Acid
- PLA-Polylactic Acid
Global Bioresorbable Implants Market: Application Analysis
Global Bioresorbable Implants Market: End-User Analysis
- Ambulatory Surgical Centers